Skip to main content
. 2019 Oct 18;21:249–260. doi: 10.1016/j.isci.2019.10.028

Figure 1.

Figure 1

Analysis of the MS Cohort Dataset

(A) Ten breast cancer cell line RNA sequencing data were analyzed according to our computational pipeline neoFusion. Two fusion neo-peptides, i.e., TAISPIAVLPR produced by OTUB1-CDC20 in HCC1806 cell line and APKSSSGFSL produced by MTSS1L-RPS15A in HCC1428 cell line, were experimentally validated to be presented by MHC I using the MS data.

(B) Peptide-spectrum matches with q-value < 0.01 were extracted by mzR R package and then visualized by xiSPEC software.

See also Table S1.